PWPS
TEVA icon

Pinnacle Wealth Planning Services’s Teva Pharmaceuticals TEVA Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$474K Buy
14,002
+1,056
+8% +$35.2K 0.05% 239
2026
Q1 		$390K Buy
12,946
+7,504
+138% +$241K 0.04% 266
2025
Q4 		$170K Buy
+5,442
New +$134K 0.02% 526
2021
Q1 		– Sell
-1,189
Closed -$11K – 1770
2020
Q4 		$11K Buy
+1,189
New +$11.4K ﹤0.01% 1366

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Pinnacle Wealth Planning Services's TEVA Position: Q2 2026 in Review

Pinnacle Wealth Planning Services increased its Teva Pharmaceuticals (TEVA) stake by 8.2% in Q2 2026, buying an estimated $35.2K and bringing the position to 14,002 shares worth $474K. The position accounts for 0.05% of the portfolio, ranked #239.

Pinnacle Wealth Planning Services first reported a position in TEVA in Q4 2020 and has held it in 4 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Pinnacle Wealth Planning Services held 14,002 shares of Teva Pharmaceuticals worth $474K as of Q2 2026.
  • Pinnacle Wealth Planning Services bought 1,056 Teva Pharmaceuticals shares in Q2 2026, an estimated $35.2K.
  • Teva Pharmaceuticals made up 0.05% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #239 holding.
  • Pinnacle Wealth Planning Services first reported a position in Teva Pharmaceuticals in Q4 2020 and has held it in 4 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.